A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC
Clinical trial NCT00000753 · COMPLETED
Trial details
- NCT number
- NCT00000753
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.